Your browser doesn't support javascript.
loading
Long-term characteristics of exudative age-related macular degeneration in Japanese patients.
Saito, Masaaki; Iida, Tomohiro; Saito, Kuniharu; Kano, Mariko; Itagaki, Kanako; Maruko, Ichiro; Sekiryu, Tetsuju.
Afiliação
  • Saito M; Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Iida T; Department of Ophthalmology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Saito K; Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Kano M; Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
  • Itagaki K; Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Maruko I; Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Sekiryu T; Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
PLoS One ; 16(12): e0261320, 2021.
Article em En | MEDLINE | ID: mdl-34905560
ABSTRACT

PURPOSE:

The present study aimed to evaluate the clinical characteristics of exudative age-related macular degeneration (AMD) in Japanese patients over a 10-year period and to compare the past our report.

METHODS:

We retrospectively reviewed 1,600 treatment-naïve patients (1,777 eyes) with exudative AMD. The 10 years were divided into 2-year phases I to V.

RESULTS:

Of the 1,600 patients, 720 (45.0%), 733 (45.8%), 98 (6.1%), and 49 (3.1%) were diagnosed with typical AMD, polypoidal choroidal vasculopathy (PCV), retinal angiomatous proliferation, and combined subtypes, respectively. The prevalence of PCV decreased from 54.7% in phase I to 46.0% at phase V. Of the 1,777 eyes, the mean baseline logarithm of the minimum angle of resolution best-corrected visual acuities (BCVAs) in phases I, II, III, IV, and V were 0.70, 0.66, 0.55, 0.50, and 0.48, respectively. Phases III, IV, and V had significantly (P = 0.0012, P<0.0001, P<0.0001, respectively) better baseline VAs compared with phase I. The mean lesion sizes in phases I, II, III, IV, and V were 8.6, 6.7, 5.3, 5.7, and 5.7 Macular Photocoagulation Study disc areas, respectively. The sizes were significantly (P<0.0001 for all comparisons) smaller in phases III, IV, and V compared with phase I.

CONCLUSIONS:

Although the prevalence of PCV decreased from 54.7% in phase I to 46.0% at phase V, PCV has nevertheless been highly prevalent in Japanese patients with AMD compared with Caucasian patients. The annual better baseline VAs and smaller lesion sizes over time might be related to development of treatment and better concerns about AMD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acuidade Visual / Neovascularização de Coroide / Degeneração Macular Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acuidade Visual / Neovascularização de Coroide / Degeneração Macular Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article